In contrast, mutations in TP53 are found in less than 6% of pediatric cancers (Chen et al., 2014a; Chen, 2013; Gröbner et al., 2018; Seki et al., 2015; Shern et al., 2014; Tirode et al., 2014). Here, TP53 is linked to cancer.